Literature DB >> 24434998

Patient-reported outcomes for the myelodysplastic syndromes: a new MDS-specific measure of quality of life.

Gregory A Abel1, Robert Klaassen, Stephanie J Lee, Nancy L Young, Laura Cannella, David P Steensma, Fabio Efficace.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24434998     DOI： 10.1182/blood-2013-11-540021

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  11 in total

Review 1.  The Value of Patient Reported Outcomes and Other Patient-Generated Health Data in Clinical Hematology.

Authors:  Hemant S Murthy; William A Wood
Journal:  Curr Hematol Malig Rep       Date:  2015-09       Impact factor: 3.952

2.  The National MDS Natural History Study: design of an integrated data and sample biorepository to promote research studies in myelodysplastic syndromes.

Authors:  Mikkael A Sekeres; Steven D Gore; Donald M Stablein; Nancy DiFronzo; Gregory A Abel; Amy E DeZern; Jesse D Troy; Dana E Rollison; John W Thomas; Myron A Waclawiw; Jane Jijun Liu; Tareq Al Baghdadi; Matthew J Walter; Rafael Bejar; Edward J Gorak; Daniel T Starczynowski; James M Foran; James R Cerhan; Lynn C Moscinski; Rami S Komrokji; H Joachim Deeg; Pearlie K Epling-Burnette
Journal:  Leuk Lymphoma       Date:  2019-05-21

Review 3.  Patient-Reported Outcomes in Myelodysplastic Syndromes and MDS/MPN Overlap Syndromes: Stepping Onto the Stage with Changing Times.

Authors:  Sagar S Patel; Aaron T Gerds
Journal:  Curr Hematol Malig Rep       Date:  2017-10       Impact factor: 3.952

Review 4.  Palliative and End-of-Life Care in Myelodysplastic Syndromes.

Authors:  Myles Nickolich; Areej El-Jawahri; Thomas W LeBlanc
Journal:  Curr Hematol Malig Rep       Date:  2016-12       Impact factor: 3.952

Review 5.  Transplantation for myelodysplastic syndromes: who, when, and which conditioning regimens.

Authors:  Wael Saber; Mary M Horowitz
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

6.  Does quality of life impact the decision to pursue stem cell transplantation for elderly patients with advanced MDS?

Authors:  A El-Jawahri; H T Kim; D P Steensma; A M Cronin; R M Stone; C D Watts; Y-B Chen; C S Cutler; R J Soiffer; G A Abel
Journal:  Bone Marrow Transplant       Date:  2016-03-21       Impact factor: 5.483

7.  Prospective international validation of the Quality of Life in Myelodysplasia Scale (QUALMS).

Authors:  Gregory A Abel; Fabio Efficace; Rena J Buckstein; Sara Tinsley; Joseph G Jurcic; Yolanda Martins; David P Steensma; Corey D Watts; Azra Raza; Stephanie J Lee; Alan F List; Robert J Klaassen
Journal:  Haematologica       Date:  2016-03-04       Impact factor: 9.941

8.  Health-related quality of life in lower-risk MDS patients compared with age- and sex-matched reference populations: a European LeukemiaNet study.

Authors:  Reinhard Stauder; Ge Yu; Karin A Koinig; Tim Bagguley; Pierre Fenaux; Argiris Symeonidis; Guillermo Sanz; Jaroslav Cermak; Moshe Mittelman; Eva Hellström-Lindberg; Saskia Langemeijer; Mette Skov Holm; Krzysztof Mądry; Luca Malcovati; Aurelia Tatic; Ulrich Germing; Aleksandar Savic; Corine van Marrewijk; Agnès Guerci-Bresler; Elisa Luño; Jackie Droste; Fabio Efficace; Alex Smith; David Bowen; Theo de Witte
Journal:  Leukemia       Date:  2018-03-06       Impact factor: 11.528

Review 9.  Management of the Older Patient with Myelodysplastic Syndrome.

Authors:  Rory M Shallis; Amer M Zeidan
Journal:  Drugs Aging       Date:  2021-08-03       Impact factor: 3.923

Review 10.  Transfusion Thresholds, Quality of Life, and Current Approaches in Myelodysplastic Syndromes.

Authors:  Ioannis Koutsavlis
Journal:  Anemia       Date:  2016-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.